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The fate of peptides that fail to bind to major
histocompatibility complex class I molecules in the
endoplasmic reticulum (ER) has remained unclear. A
recent study has revealed that these peptides exit the
ER via the Sec61 channel and compete for this pathway
with misfolded proteins. 
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Antigen recognition by the immune system occurs by
humoral (or antibody-mediated) immunity and cell-medi-
ated immunity. The cell-mediated response involves
helper T cells, which aid antibody production, and cyto-
toxic T cells, which kill virus-infected and tumour cells.
The cytotoxic T cells therefore need to distinguish
between healthy and diseased cells and do so by sampling
the protein content of a cell in the form of peptides bound
to cell surface major histocompatibility complex (MHC)
class I molecules. If the MHC class I molecules bind pep-
tides derived from viral or malignant proteins, cytotoxic T
cells are activated and eliminate the infected or trans-
formed cell. 
The MHC class I complex is assembled in the endoplas-
mic reticulum (ER). Peptide binding forms an integral
part of the assembly process, as bound peptide stabilises
MHC class I complexes for transport from the ER to the
cell surface [1]. The majority of antigenic peptides are
generated in the cytosol by proteasomes and are then
transported across the ER membrane via the transporter
associated with antigen processing (TAP). Many peptides
transported into the ER do not associate with MHC class I
molecules, however. A recent study [2] has provided
insights into the fate of such peptides, demonstrating
an interesting link between peptide and protein export
from the ER. 
Peptides are delivered to the ER via TAP
TAP is a member of the ATP-binding cassette (ABC)
transporter superfamily, whose members translocate mol-
ecules unidirectionally across membranes, utilising energy
from ATP hydrolysis [3]. TAP is formed by two integral
ER membrane proteins, TAP1 and TAP2, and the
peptide-binding site is formed by the membrane domains
of TAP1 and TAP2. TAP can bind and translocate a range
of different-sized peptides, although peptides of 8–12
amino acids appear to be optimal. TAP substrates are
therefore the same size or slightly longer than peptides
that bind to MHC class I molecules (8–10 amino acids).
TAP has a relatively broad specificity in terms of peptide
sequence, although there are some preferences for the
amino acids at the amino and carboxyl termini of the
peptide. In contrast to TAP, MHC class I molecules are
much more selective in their peptide binding. Selective
peptide binding to MHC class I molecules is controlled by
allele-specific peptide-binding motifs. Although any
single MHC class I allele encodes a molecule that can
bind a broad range of peptides, a significant proportion, if
not the majority, of TAP-translocated peptides will not
associate with MHC class I molecules. 
So, what happens to peptides that fail to find a suitable
MHC class I binding partner? Some of the earliest studies
demonstrating peptide transport by TAP found that
imported reporter peptides were rapidly exported from
the ER back to the cytosol [4]. It was not until Neefjes
and colleagues [5] introduced the use of reporter peptides
bearing N-linked glycosylation consensus motifs, which
allowed peptides entering the ER to become ‘tagged’ by
glycosylation, that an accumulation of peptides in the ER
lumen was detected. Although the TAP-translocated pep-
tides were found to be removed from the ER in a temper-
ature- and ATP-dependent process [4,6,7], the nature of
this export pathway remained unclear until recently. 
Peptides exit the ER via the protein translocation channel
There are a number of possible fates for peptides that fail
to bind MHC class I molecules, including degradation in
the ER lumen, TAP-mediated export back to the cytosol or
export to the cytosol via another channel in the ER mem-
brane. In a recent elegant study published in Immunity,
Koopmann et al. [2] discriminate between these possibili-
ties. This group confirmed that TAP-imported peptides
rapidly exit the ER with half-times ranging from 1.5 to 4
minutes and that this export requires ATP, but is clearly
independent of TAP. For proteins, there are two known
exit pathways from the ER — forward via the secretory
pathway or back across the ER membrane to the cytosol via
the Sec61 channel in a process known as retrograde protein
translocation [8]. Initially described for unassembled MHC
class I heavy chains, retrograde translocation to the cytosol
is now recognised as the main disposal route for misfolded
soluble and membrane proteins [9,10]. Proteins exported
through the Sec61 channel are subsequently degraded by
proteasomes in the cytosol [8].
Although Sec61 allows proteins to exit the ER, the essen-
tial function of this channel is to mediate secretory protein
import into the ER, which, in mammalian cells, is largely
cotranslational [11]. During this process, the cytosolic end
of the channel is sealed by the ribosome, which is tightly
bound to Sec61p. The channel is formed by several het-
erotrimeric Sec61 complexes composed of Sec61α, β, and
γ subunits, where Sec61α is the channel-forming subunit.
The discovery that the Sec61 channel can transport pro-
teins in either direction is relatively recent [12–14]. It
remains as yet unclear how bidirectional protein transport
through the Sec61 channel is regulated, whether specific
accessory proteins are required for transport in a specific
direction, and how the substrates for retrograde transport
are recognised and targeted to the channel [10]. 
Some bacterial and plant toxins use the Sec61 channel to
gain entry to the cytosol [15]. Cholera toxin, for example,
enters mammalian cells by endocytosis, travels retrogradely
through the secretory pathway back to the ER and, cam-
ouflaged as a misfolded protein, uses the Sec61 channel to
enter the cytosol [16]. Another toxin, ricin, probably uses
the same route [17]. The Sec61 channel can transport mis-
folded proteins and toxins whether or not they are N-gly-
cosylated [10]. In a study based on a yeast cell-free system
and a large number of sec61 mutants, Gillece and col-
leagues [18] showed recently that transport of glycopep-
tides from the ER lumen to the cytosol is also dependent
on Sec61p. In this system, exit of glycopeptides can be
inhibited by ribosomes binding to the cytosolic side of the
Sec61 channel.
Koopmann et al. [2] now demonstrate that removal of
TAP-imported peptides from the ER lumen similarly
occurs via the Sec61 channel (Figure 1). This group shows
that peptide export is blocked by Pseudomonas aeruginosa
exotoxin, which binds Sec61α and presumably competes
with peptides for retrograde translocation. In addition,
Koopmann et al. [2] demonstrate that an increased concen-
tration of peptides in the ER lumen interferes with the
transport to the cytosol of an unassembled subunit of the
MHC class I complex, β2 microglobulin, which most
likely also exits via the Sec61 channel. It seems, therefore,
that TAP-translocated peptides and proteins can compete
for translocation back to the cytosol.
So what happens when TAP-translocated peptides enter
the ER? The intermediate steps in this process require
further elucidation, but there are clues to the identities of
the main players. In addition to transporting peptides into
the ER, TAP acts as a molecular scaffold for the final stage
of assembly of the peptide–MHC class I complex — the
loading of peptide onto MHC class I molecules [1]. The
proximity of MHC class I molecules to newly translocated
peptides gives them ‘first go’ at peptide binding. TAP-
translocated peptides that fail to bind MHC class I mol-
ecules can be found in the ER lumen in association with a
number of ER resident chaperone proteins including
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Figure 1
Fates of peptides and proteins in the ER
lumen. After import through TAP (1), antigenic
peptides bind to MHC class I molecules (2);
this allows packaging of the loaded MHC
class I complex into ER-to-Golgi transport
vesicles (3). The TAP-imported peptides that
cannot bind to MHC class I molecules are
exported back to the cytosol via the Sec61
channel (2*,3*). Secretory proteins enter the
ER co-translationally through the Sec61
channel (4), fold with the help of chaperones
(5) and are packaged into budding transport
vesicles (6). Proteins that fail to fold are
targeted back to the Sec61 channel and
retrogradely translocated to the cytosol (6*)
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protein disulphide isomerase (PDI), calreticulin, gp96 and
Erp57, although PDI appears to be the major peptide sink
[19–21]. These proteins are important components of the
ER protein folding machinery required for assembly of
nascent polypeptides. Export of peptides from the ER
into the cytoplasm may therefore be necessary to reduce
competition between peptides and nascent proteins for
these chaperone proteins. 
Koopmann et al. [2] find that peptide export back to the
cytosol can be driven by non-hydrolysable ATP analogues,
suggesting that the release of peptide from the ER may
involve ATP-binding-induced conformational changes
rather than ATP hydrolysis. Such conformational changes
have been observed to regulate the association of proteins
with a number of chaperones including BiP, gp96 and cal-
nexin. Retrograde transport of soluble misfolded proteins
through the Sec61 channel does require a substrate-spe-
cific set of ER-lumenal chaperones, which may be respon-
sible for targeting the proteins to the channel [22].
Likewise, retrograde transport of toxins is dependent on
ER-lumenal proteins [16]. In contrast, mutations in BiP
and PDI that cause defects in protein export have no
effect on glycopeptide transport from the yeast ER [18], so
different processes seem to have different requirements
for chaperone proteins. Whether ER-lumenal chaperones
are actively involved in the export of TAP substrates from
the mammalian ER or whether export simply requires
ATP-induced release of the peptides from the chaperones
remains unclear.
Peptides and proteins compete for retrograde
translocation
Koopmann et al. [2] clearly show that TAP-translocated
peptides can compete with soluble proteins, such as β2
microglobulin and Pseudomonas exotoxin for Sec61-medi-
ated transport back to the cytosol. This intersection of
peptide and protein export pathways at the Sec61 channel
has important implications. TAP is constitutively expressed
in most nucleated cells and it is tempting to speculate on
the consequences of TAP overexpression. TAP induction
by proinflammatory mediators, including interferon-γ, will
result in a rapid rise in the peptide concentration within
the ER. Is there an associated mechanism to promote
export of peptides from the ER? Misfolded ER proteins
can induce the ‘unfolded protein response’ (UPR) in
which an accumulation of unfolded proteins is sensed by
the IRE1 kinase resulting in transcriptional induction of
UPR target genes [23], many of which encode ER resi-
dent chaperones. It is not yet known whether the accumu-
lation of peptides in the ER also stimulates the induction
of the UPR. Induction of this response could occur as a
direct consequence of peptide accumulation, or indirectly
as a result of competition between peptides and proteins
for retrograde translocation leading to an accumulation of
unfolded proteins in the ER. 
When misfolded secretory proteins reach the cytosol they
are degraded by proteasomes [10]. The fate of peptides in
the cytosol is not yet known, but there must be a mecha-
nism that promotes their degradation and prevents a
second round of translocation by TAP into the ER. By
identifying the Sec61 channel as the exit route for both
peptides and proteins from the ER, Koopmann et al. [2]
have discovered an important connection between protein
and peptide homeostasis in the ER. Their results suggest
that stringent controls on TAP-mediated import of pep-
tides into the ER are required to maintain protein quality
control in the ER.
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